EyePoint Pharmaceuticals outlines Phase 3 trials for Duravyu in diabetic macular edema, backed by $150 million in new funding ...
Your vision shapes how you live each moment. Protect it, strengthen it, and let it bring you closer to the life you want.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback